Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, and Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Virgen de la Arrixaca), 30120 Murcia, Spain.
Int J Mol Sci. 2019 Sep 19;20(18):4649. doi: 10.3390/ijms20184649.
Inherited or acquired photoreceptor degenerations, one of the leading causes of irreversible blindness in the world, are a group of retinal disorders that initially affect rods and cones, situated in the outer retina. For many years it was assumed that these diseases did not spread to the inner retina. However, it is now known that photoreceptor loss leads to an unavoidable chain of events that cause neurovascular changes in the retina including migration of retinal pigment epithelium cells, formation of "subretinal vascular complexes", vessel displacement, retinal ganglion cell (RGC) axonal strangulation by retinal vessels, axonal transport alteration and, ultimately, RGC death. These events are common to all photoreceptor degenerations regardless of the initial trigger and thus threaten the outcome of photoreceptor substitution as a therapeutic approach, because with a degenerating inner retina, the photoreceptor signal will not reach the brain. In conclusion, therapies should be applied early in the course of photoreceptor degeneration, before the remodeling process reaches the inner retina.
遗传性或获得性光感受器变性是世界上导致不可逆性失明的主要原因之一,属于一组视网膜疾病,最初影响位于外视网膜的视杆细胞和视锥细胞。多年来,人们一直认为这些疾病不会扩散到内视网膜。然而,现在已知光感受器的丧失会导致不可避免的连锁反应,导致视网膜的神经血管发生变化,包括视网膜色素上皮细胞的迁移、“视网膜下血管复合物”的形成、血管移位、视网膜节细胞(RGC)轴突被视网膜血管绞杀、轴突运输改变,最终导致 RGC 死亡。这些事件是所有光感受器变性的共同特征,与最初的触发因素无关,因此威胁到光感受器替代作为一种治疗方法的效果,因为随着内视网膜的变性,光感受器信号将无法到达大脑。总之,应该在光感受器变性的早期,即在重塑过程到达内视网膜之前,应用治疗方法。